DelveInsight’s “Cervical Dystonia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Cervical Dystonia, historical and forecasted epidemiology as well as the Cervical Dystonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Cervical Dystonia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Cervical Dystonia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cervical Dystonia Market Insights
Cervical Dystonia Overview
According to NORD (National Organization of Rare Disorders), cervical dystonia (CD), also known as spasmodic torticollis, is a specific form of dystonia affecting the head and neck. It is a rare neurological disorder that originates in the brain. It is the most common form of focal dystonia (dystonia affecting one particular area of the body).
Some of the key facts of the Cervical Dystonia Market Report:
The Cervical Dystonia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
The exact incidence or prevalence of cervical dystonia in the general population is unknown but is estimated to be about 60,000 people in the United States
According to the LaHue et al., the Cervical Dystonia incidence was 1.18/100,000 person-years. Moreover, the incidence of Cervical Dystonia was 3.5 times greater for women than for men
Among the various subtypes of Cervical Dystonia, defined according to the Col–Cap concept, the most common primary form is torticaput (49%), the second most common is laterocaput (16.7%)
Key Cervical Dystonia Companies: Revance Therapeutics, AEON Biopharma, Allergan, Eisai, Ipsen Pharma, Merz Pharma, US WorldMeds, and others
Key Cervical Dystonia Therapies: Daxibotulinum toxin A, ABP-450, and others
The Cervical Dystonia epidemiology based on gender analyzed that Cervical Dystonia affects women approximately twice as often as men
Get a Free sample for the Cervical Dystonia Market Report –
Key benefits of the Cervical Dystonia Market report:
Cervical Dystonia market report covers a descriptive overview and comprehensive insight of the Cervical Dystonia Epidemiology and Cervical Dystonia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Cervical Dystonia market report provides insights on the current and emerging therapies.
Cervical Dystonia market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Cervical Dystonia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Cervical Dystonia market.
Download the report to understand which factors are driving Cervical Dystonia epidemiology trends @ Cervical Dystonia Epidemiological Insights
Cervical Dystonia Market
The dynamics of the Cervical Dystonia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Cervical Dystonia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cervical Dystonia Epidemiology Segmentation:
The Cervical Dystonia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Cervical Dystonia
Prevalent Cases of Cervical Dystonia by severity
Gender-specific Prevalence of Cervical Dystonia
Diagnosed Cases of Episodic and Chronic Cervical Dystonia
Cervical Dystonia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cervical Dystonia market or expected to get launched during the study period. The analysis covers Cervical Dystonia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cervical Dystonia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Cervical Dystonia market share @ Cervical Dystonia market forecast
Cervical Dystonia Therapies and Key Companies
Daxibotulinum toxin A: Revance Therapeutics
ABP-450: AEON Biopharma
Cervical Dystonia Market Drivers
Expected approval of late-stage molecules
Increasing aging population in the 7MM
Scope of the Cervical Dystonia Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan] Key Cervical Dystonia Companies: Revance Therapeutics, AEON Biopharma, Allergan, Eisai, Ipsen Pharma, Merz Pharma, US WorldMeds, and others
Key Cervical Dystonia Therapies: Daxibotulinum toxin A, ABP-450, and others
Cervical Dystonia Therapeutic Assessment: Cervical Dystonia current marketed and Cervical Dystonia emerging therapies
Cervical Dystonia Market Dynamics: Cervical Dystonia market drivers and Cervical Dystonia market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Cervical Dystonia Unmet Needs, KOL’s views, Analyst’s views, Cervical Dystonia Market Access and Reimbursement
Cervical Dystonia Market Barriers
Availability of alternative therapies
Side effects of Botulinum toxin
Table of Contents
1. Cervical Dystonia Market Report Introduction
2. Executive Summary for Cervical Dystonia
3. SWOT analysis of Cervical Dystonia
4. Cervical Dystonia Patient Share (%) Overview at a Glance
5. Cervical Dystonia Market Overview at a Glance
6. Cervical Dystonia Disease Background and Overview
7. Cervical Dystonia Epidemiology and Patient Population
8. Country-Specific Patient Population of Cervical Dystonia
9. Cervical Dystonia Current Treatment and Medical Practices
10. Cervical Dystonia Unmet Needs
11. Cervical Dystonia Emerging Therapies
12. Cervical Dystonia Market Outlook
13. Country-Wise Cervical Dystonia Market Analysis (2019–2032)
14. Cervical Dystonia Market Access and Reimbursement of Therapies
15. Cervical Dystonia Market Drivers
16. Cervical Dystonia Market Barriers
17. Cervical Dystonia Appendix
18. Cervical Dystonia Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
To know more about Cervical Dystonia treatment, visit @ Cervical Dystonia Medications
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States